Literature DB >> 20966507

[Akt kinase: a key regulator of metabolism and progression of tumors].

Anna Krześlak1.   

Abstract

The serine/threonine protein kinase Akt is a major transducer of the phosphoinositide 3-kinase pathway and plays a crucial role in regulation of cellular processes such as growth, metabolism, survival and proliferation. Mammalian cells are characterized by the expression of three different Akt isoforms (Akt1, Akt2, Akt3), encoded by distinct genes. Increased expression and activation of Akt observed in many human cancers is usually caused by amplification or mutation of Akt genes, amplification and activating mutation of the catalytic subunit of PI3K or deletion and mutations of phosphatidylinositol-3,4,5-triphosphate phosphatase--PTEN. Although activation of Akt alone is believed to be insufficient for tumorigenesis, it contributes to cancer progression by inhibiting apoptosis, promoting changes in metabolism and proliferation of cells and regulating their migration and invasion capabilities. Recent studies have provided evidence that depending on the cell type each specific Akt isoform may play a positive or negative role in cell migration and invasion. Akt is also involved in regulation of tumor angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20966507

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  7 in total

1.  Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.

Authors:  Monika Paul-Samojedny; Adam Pudełko; Renata Suchanek-Raif; Małgorzata Kowalczyk; Anna Fila-Daniłow; Paulina Borkowska; Jan Kowalski
Journal:  Tumour Biol       Date:  2014-12-14

2.  Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation.

Authors:  Yan-Jing Shen; Xue-Xin Zhu; Xian Yang; Bo Jin; Jin-Jian Lu; Bin Ding; Zhi-Shan Ding; Su-Hong Chen
Journal:  J Nat Med       Date:  2014-03-05       Impact factor: 2.343

Review 3.  O-GlcNAcylation and Metabolic Reprograming in Cancer.

Authors:  Paweł Jóźwiak; Ewa Forma; Magdalena Bryś; Anna Krześlak
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-09       Impact factor: 5.555

4.  Antagonistic Effects of CAPE (a Component of Propolis) on the Cytotoxicity and Genotoxicity of Irinotecan and SN38 in Human Gastrointestinal Cancer Cells In Vitro.

Authors:  Gabriela Gajek; Beata Marciniak; Jarosław Lewkowski; Renata Kontek
Journal:  Molecules       Date:  2020-02-04       Impact factor: 4.411

5.  The role of galectins‑1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer (Review).

Authors:  Aleksandra Mielczarek-Palacz; Zdzisława Kondera-Anasz; Marta Smycz-Kubańska; Aleksandra Englisz; Aleksandra Janusz; Patrycja Królewska-Daszczyńska; Dominika Wendlocha
Journal:  Mol Med Rep       Date:  2022-03-16       Impact factor: 2.952

6.  Inositol Hexaphosphate Inhibits Proliferation and Induces Apoptosis of Colon Cancer Cells by Suppressing the AKT/mTOR Signaling Pathway.

Authors:  Małgorzata Kapral; Joanna Wawszczyk; Katarzyna Jesse; Monika Paul-Samojedny; Dariusz Kuśmierz; Ludmiła Węglarz
Journal:  Molecules       Date:  2017-10-03       Impact factor: 4.411

7.  Elevated YKL-40 serum levels may contribute to wet age-related macular degeneration via the ERK1/2 pathway.

Authors:  Yue Bin; Yanyao Liu; Shaoqiu Jiang; Hui Peng
Journal:  FEBS Open Bio       Date:  2021-09-30       Impact factor: 2.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.